MedWellAI, Inc.
corporate_fare Company Profile
MedWellAI, Inc. (OTC:MWAI) is a publicly traded company in the Crypto Assets sector. Wiseek has independently scored 4 items for MWAI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-06-18, rated 9/10. Across its 4 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for MWAI spans 5, 10-Q, 8-K.
Recent high-impact activity:
- CEO Steve Rubakh Discloses $281K Stock Purchase, Now Owns ~50.8% of MedWellAI
- MedWellAI Reports Worsening $7.6M Working Capital Deficit and New $6.5M Convertible Preferred Stock Liability Amid Strategic Shift
- MedWellAI Increases Authorized Series B Convertible Preferred Stock by 50%
- MedWellAI Reports Going Concern, $7.5M Working Capital Deficit, and Internal Control Weaknesses
Financial Snapshot
Short Interest & Short Volume
3.04 days to coverFINRA reported short interest of 4,650 shares in MWAI as of the September 15, 2026 settlement, a 43.3% increase from the prior period — about 3.0 days to cover at its recent average daily volume. On September 29, 2026, 15.0% of MWAI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.